계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Vivo Capital
About
Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM
- 51 - 100
Highlights
Details
- Industries
- Finance,Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 1996
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Investor Type
- PE,Venture Capital
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts.The firm operates as a multi-fund investment platform, covering growth equity, privateequity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Rgenta Therapeutics
|
Series A | $52M | Biotechnology | — |
|
Oct 27, 2022
Neocis
|
Series D | $40M | Dental | — |
|
Jul 6, 2022
Tebra
|
Series B | $72M | Electronic Health Record (EHR) | — |
|
May 25, 2021
Rgenta Therapeutics
|
Seed | $18M | Biotechnology | — |
|
May 6, 2021
Aerobiotix
|
Series Unknown | $25M | Health Care | Yes |
